Abstract
The importance of glycemic control in preventing the chronic and devastating complications of diabetes is well established. Insulin administration is an important therapeutic option for managing diabetes, particularly for patients with profound insulin deficiency. Many insulin formulations are on the market, including short-acting insulin analogues, inhaled insulin, concentrated insulin, and basal insulin. Each category has a unique onset, peak, and duration of action. This article reviews the differing pharmacokinetic and pharmacodynamic properties and safety and efficacy data, and discusses the implications for clinical practice.
| Original language | English (US) |
|---|---|
| Pages (from-to) | S27-S33 |
| Journal | Cleveland Clinic Journal of Medicine |
| Volume | 83 |
| Issue number | 5 |
| DOIs | |
| State | Published - May 1 2016 |
Fingerprint
ASJC Scopus subject areas
- Medicine(all)
Cite this
New insulin preparations : A primer for the clinician. / Meneghini, Luigi.
In: Cleveland Clinic Journal of Medicine, Vol. 83, No. 5, 01.05.2016, p. S27-S33.Research output: Contribution to journal › Review article
}
TY - JOUR
T1 - New insulin preparations
T2 - A primer for the clinician
AU - Meneghini, Luigi
PY - 2016/5/1
Y1 - 2016/5/1
N2 - The importance of glycemic control in preventing the chronic and devastating complications of diabetes is well established. Insulin administration is an important therapeutic option for managing diabetes, particularly for patients with profound insulin deficiency. Many insulin formulations are on the market, including short-acting insulin analogues, inhaled insulin, concentrated insulin, and basal insulin. Each category has a unique onset, peak, and duration of action. This article reviews the differing pharmacokinetic and pharmacodynamic properties and safety and efficacy data, and discusses the implications for clinical practice.
AB - The importance of glycemic control in preventing the chronic and devastating complications of diabetes is well established. Insulin administration is an important therapeutic option for managing diabetes, particularly for patients with profound insulin deficiency. Many insulin formulations are on the market, including short-acting insulin analogues, inhaled insulin, concentrated insulin, and basal insulin. Each category has a unique onset, peak, and duration of action. This article reviews the differing pharmacokinetic and pharmacodynamic properties and safety and efficacy data, and discusses the implications for clinical practice.
UR - http://www.scopus.com/inward/record.url?scp=85011541179&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85011541179&partnerID=8YFLogxK
U2 - 10.3949/ccjm.83.s1.05
DO - 10.3949/ccjm.83.s1.05
M3 - Review article
C2 - 27176680
AN - SCOPUS:85011541179
VL - 83
SP - S27-S33
JO - Cleveland Clinic Journal of Medicine
JF - Cleveland Clinic Journal of Medicine
SN - 0891-1150
IS - 5
ER -